Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: lwd who wrote (726)	6/16/1998 5:18:00 PM
From: Boyce Burge	Respond to of 1728

lwd... nice of you to say hello. Yahoo is very accessible, and they may upstage SI. But SI has a little more class... it lets you see who you are talking to, and what else they have been posting. This kind of interactivity is very useful, and what the internet is all about. If you liked reading about AFFX, you should look at the INCY thread for Rocketmans recent post on the annual meeting. Very complete and gives some info on AFFX. It seems to me that INCY will do better in the short run with their genes, database and expression chips, but that eventually the ability of AFFX to put every important allele on a chip and read your genetic fate (maybe in 5+ years) will ultimately be the big Diagnostic pay off. So own both, I say. Im out of CBMI since their clinical was only so so 3 months back. I made a new years resolution not to buy 1 drug biotech companies, and currently own just AFFX, INCY, and CEGE... and an equal amount of big pharma.